Presented at #ASH24:

The addition of blinatumomab after induction chemotherapy in children with standard-risk disease of average or high risk of relapse significantly improved disease-free survival.

Full AALL1731 trial results: https://nej.md/49CVkc1

#medsky
Post image

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service